ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2469

The Lymphocyte Repertoire in Juvenile Dermatomyositis

Lauren A. Henderson1, Edwin Anderson1, Robert C. Fuhlbrigge1,2, Luigi D. Notarangelo1,3,4 and Susan Kim1, 1Division of Immunology, Boston Children's Hospital, Boston, MA, 2Department of Dermatology, Brigham and Women's Hospital, Boston, MA, 3The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, MA, 4Harvard Stem Cell Institute, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: juvenile dermatomyositis, pediatric rheumatology and regulatory cells, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Pediatric Rheumatology - Pathogenesis and Genetics Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  In adult dermatomyositis, clonal populations of T lymphocytes with shared variable (V) gene usage have been identified, suggesting aberrant T cell responses to a common antigen.  A CD4+T cell subset, regulatory T (Treg) cells, has recently been identified as important mediators of muscle tissue repair.  A diverse Treg repertoire is thought to be important in maintaining Treg function and may contribute to the Treg response to muscle damage.  Little is known about the T cell repertoire in juvenile dermatomyositis (JDM); further, the Treg repertoire in human inflammatory myopathies has not been evaluated.  Therefore, we employed next generation sequencing to characterize the Treg and effector T (Teff) cell repertoires in JDM.     

Methods:  Peripheral blood (PB) was obtained from JDM patients (n=6) at disease onset and healthy children (n=3).  Treg (CD4+CD25+CD127lo) and Teff (CD4+CD25–) cells were isolated from PB mononuclear cells by fluorescence-activated cell sorting.  The T cell receptor (TCR) β chain was amplified by multiplex PCR with genomic DNA serving as the template (ImmunoSEQTM).  Illumina HiSeq platform was used for sequencing.  Wilcoxon sign ranked tests were used to compare the clonality index and normalized Shannon entropy in patients and controls.  2-way ANOVA with Bonferroni correction was used to compare TCRVβ family usage in patients versus controls. 

Results:  Three males and 3 females with JDM, average age 7.0 years (range:  3.3-9.4 years), were studied.  The average disease duration was 7 months, and the average MMT8 score was 69.6.  Five of the patients were evaluated before the initiation of any immunosuppressive therapy.  Treg and Teff repertoire clonality and diversity were similar in JDM patients and controls.  In JDM Treg and Teff subsets, TCRVβ families 7, 19, and 28 were used more and TCRVβ families 2, 3, 5, 6 were used less than in controls (p<0.0001 for both Treg and Teff cells).  In particular, TCRVβ7 skewing was most striking, and this Vβ family was used more than twice as often in JDM PB Treg and Teff cells compared to controls.  

Conclusion:  Skewed TCRVβ family usage was observed in JDM patients at disease onset.  Increased usage of TCRVβ7 was observed in JDM PB Treg and Teff cells, and this Vβ family has been linked with other autoimmune conditions including type I diabetes and anti-phospholipid syndrome.  Our early pilot results suggest that T cell repertoire abnormalities may contribute to disease pathogenesis in JDM.  Further studies are planned to evaluate the T cell repertoire in JDM muscle and skin biopsies, as well as longitudinally over the course of disease.


Disclosure: L. A. Henderson, None; E. Anderson, None; R. C. Fuhlbrigge, None; L. D. Notarangelo, None; S. Kim, None.

To cite this abstract in AMA style:

Henderson LA, Anderson E, Fuhlbrigge RC, Notarangelo LD, Kim S. The Lymphocyte Repertoire in Juvenile Dermatomyositis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-lymphocyte-repertoire-in-juvenile-dermatomyositis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-lymphocyte-repertoire-in-juvenile-dermatomyositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology